By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
The market sentiment in the next few months is likely to be quite positive for Pfizer. Read why I maintain my strong buy ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...
Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...
Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...
Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...
Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...